TELA Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
TELA Bio, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue69.3058.4541.4229.4618.21
Cost of Revenue22.4318.3413.5710.356.68
Gross Profit46.8740.1127.8519.1211.54
Operating Expenses
Research & Development8.819.628.946.744.26
Selling, General & Administrative79.3774.5757.1141.5232.25
Operating Expenses88.5684.1966.8648.5736.81
Operating Income-41.70-44.08-39.01-29.45-25.28
Other Income/Expense
Interest Income0.000.000.000.000.00
Interest Expense-5.295.22-4.05-3.60-3.56
Other Income/Expense1.422.63-0.01-0.230.05
Income
Income Before Tax-37.99-46.66-44.30-33.28-28.79
Income Tax Expense-0.140.000.000.000.00
Net Income-37.84-46.66-44.30-33.28-28.79
Net Income - Continuous Operations-37.84-46.66-44.30-33.280.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-40.68-40.63-37.82-28.92-24.75
EBIT-41.70-41.44-39.01-29.45-25.28
Depreciation & Amortization1.010.811.190.540.53
Earnings Per Share
Basic EPS-1.00-2.00-3.00-2.00-2.00
Diluted EPS-1.00-2.00-3.00-2.00-2.00
Basic Shares Outstanding28.5322.8716.2714.4712.93
Diluted Shares Outstanding28.5322.8716.2714.4712.93